VANGUARD GROUP INC - AGILE THERAPEUTICS INC ownership

AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 82 filers reported holding AGILE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$812,000
-63.0%
3,877,347
-13.7%
0.00%
Q4 2021$2,194,000
-44.4%
4,494,704
+9.5%
0.00%
Q3 2021$3,946,000
-27.7%
4,104,8480.0%0.00%
Q2 2021$5,460,000
-40.1%
4,104,848
-6.3%
0.00%
Q1 2021$9,108,000
-27.4%
4,378,517
+0.1%
0.00%
Q4 2020$12,550,000
+8.2%
4,372,776
+14.7%
0.00%
Q3 2020$11,594,000
+6.6%
3,813,823
-2.5%
0.00%
Q2 2020$10,878,000
+71.7%
3,912,952
+14.9%
0.00%
Q1 2020$6,337,000
-2.9%
3,406,889
+30.5%
0.00%
Q4 2019$6,527,000
+137.3%
2,610,971
+12.5%
0.00%
Q3 2019$2,751,000
+8.7%
2,321,726
+34.0%
0.00%
Q2 2019$2,530,000
+122.1%
1,732,648
+129.8%
0.00%
Q1 2019$1,139,000
+181.9%
753,976
+7.6%
0.00%
Q4 2018$404,000
+0.7%
700,992
-35.9%
0.00%
Q3 2018$401,000
-24.9%
1,093,193
+1.0%
0.00%
Q2 2018$534,000
-79.9%
1,081,945
+4.7%
0.00%
Q1 2018$2,654,000
-0.6%
1,032,987
+4.1%
0.00%
Q4 2017$2,670,000
-10.6%
992,689
+48.2%
0.00%
Q3 2017$2,988,000
+49.4%
670,032
+25.7%
0.00%
Q2 2017$2,000,000
-22.1%
533,118
-33.5%
0.00%
Q1 2017$2,568,000
+1.1%
801,114
+79.8%
0.00%
Q4 2016$2,539,000
-10.9%
445,579
+9.1%
0.00%
Q3 2016$2,850,000
-0.6%
408,324
+8.4%
0.00%
Q2 2016$2,867,000
+23.3%
376,728
+0.6%
0.00%
Q1 2016$2,325,000
+72.7%
374,427
+171.6%
0.00%
Q4 2015$1,346,000
-99.3%
137,856
-97.2%
0.00%
-100.0%
Q3 2015$187,927,000
+30911.1%
4,893,419
+6828.8%
0.01%
Q2 2015$606,000
+134.9%
70,624
+153.9%
0.00%
Q1 2015$258,000
+116.8%
27,811
+43.3%
0.00%
Q4 2014$119,00019,4110.00%
Other shareholders

There were no reported owners of AGILE THERAPEUTICS INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of AGILE THERAPEUTICS INC shareholders